(5-Fluoro-2-(N-methylsulfamoyl)phenyl)boronic acid, 95.0%, 5g

3-Bromo-N,N-diethyl-5-nitropyridin-2-amine, 95.0%, 5g

tert-Butyl 1-bromo-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate, 95.0%, 10g

1-Benzyl-4-formylpiperidine, 97.0%, 10g

4-Methylpiperidin-4-ol hydrochloride, 95.0%, 5g

2-(2-Bromophenoxy)-N-methylacetamide, 95.0%, 1g

Diformylimide sodium salt, 90.0%, 500g

Sample tub Type 2116, 250 ml, 4 Piece(s)

3-Amino-N,N-diethyl-4-methoxybenzenesulfonamide, 98.0%, 25g

2-Amino-4-tert-butylbenzoic acid, 97.0%, 25g

TERT-BUTYL 4-((2-AMINOBENZYL)AMINO)PIPERIDINE-1-CARBOXYLATE, 95.0%, 100mg

Methyl 2-(quinolin-2-yl)acetate, 95.0%, 100mg

(2S,3R)-3-(((Benzyloxy)carbonyl)amino)-2-hydroxy-4-phenylbutanoic acid, 95.0%, 25g